References
- Skibola C F, Curry J D, Nieters A. Genetic susceptibility to lymphoma. Haematologica 2007; 92: 960–969
- Rothman N, Skibola C F, Wang S S, Morgan G, Lan Q, Smith M T, et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol 2006; 7: 27–38
- Lech-Maranda E, Baseggio L, Charlot C, Rigal D, Berger F, Jamroziak K, et al. Genetic polymorphisms in the proximal IL-10 promoter and susceptibility to non-Hodgkin lymphoma. Leuk Lymphoma 2007; 48: 2235–2238
- Lech-Maranda E, Baseggio L, Bienvenu J, Charlot C, Berger F, Rigal D, et al. Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma. Blood 2004; 103: 3529–3534
- Wang S S, Cerhan J R, Hartge P, Davis S, Cozen W, Severson R K, et al. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-hodgkin lymphoma. Cancer Res 2006; 66: 9771–9780
- Morton L M, Wang S S, Devesa S S, Hartge P, Weisenburger D D, Linet M S. Lymphoma incidence patterns by WHO subtype in the United States, 1992 – 2001. Blood 2006; 107: 265–276